source
- Roche stakes $700M on Nurix’s protein-degrading drugPotentially worth up to $2.3 billion, the collaboration is a bet that drugs able to eliminate the “BTK” enzyme will prove superior to existing medicines that block its activity.BioPharma Dive · 1mo ago↗ source
- GoHealth files for bankruptcy, as Medicare Advantage insurers pull backThe volatile Medicare Advantage market can now count GoHealth as a casualty. GoHealth, a health insurance marketplace focused on seniors, on Sunday voluntarily filed for Chapter 11 bankruptcy in th…Endpoints · 1mo ago↗ source
- Tango data add to growing momentum for pancreatic cancer drugsA combination involving Tango’s experimental therapy appeared to boost response rates in a small clinical trial well beyond what would be expected, sparking a share surge.